InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by Weinberg Uri, Directeur Scientifique. Insider active across 1 companies, notably NovoCure Ltd. In total, 7 disclosures have been published. The latest transaction was disclosed on 3 March 2022 — Attribution. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations7 total
017,371 shares0
Ordinary Shares
SEC:0001645113-22-000021:0·
€1,97435 shares@ €56.40870.0001% mcap1.2% of flow
Ordinary Shares
SEC:0001645113-22-000008·
€1,97435 shares@ €56.40870.0001% mcap0.6% of flow
Ordinary Shares
SEC:0001645113-22-000008:0·
€13,104113 shares@ €115.96410.0009% mcap7.9% of flow
Ordinary Shares
SEC:0001645113-21-000089·
€13,104113 shares@ €115.96410.0009% mcap4.0% of flow
Ordinary Shares
SEC:0001645113-21-000089:0·
€150,6603,846 shares@ €39.17330.010% mcap90.9% of flow
Ordinary Shares
SEC:0001645113-21-000066·
€150,6603,846 shares@ €39.17330.010% mcap45.5% of flow
Ordinary Shares
SEC:0001645113-21-000066:0·
7 of 7 declarations
About Weinberg Uri
Uri Weinberg is the Chief Science Officer of NovoCure Ltd. In this role, he is responsible for leading the company's scientific and research initiatives. His expertise in biomedical sciences is essential for the development of new therapies and for innovation within the organization.
